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Abstract Amino acids not only participate in intermedi-
ary metabolism but also stimulate insulin-mechanistic tar-
get of rapamycin (MTOR)-mediated signal transduction
which controls the major metabolic pathways. Among
these is the pathway of autophagy which takes care of the
degradation of long-lived proteins and of the elimination of
damaged or functionally redundant organelles. Proper
functioning of this process is essential for cell survival.
Dysregulation of autophagy has been implicated in the
etiology of several pathologies. The history of the studies
on the interrelationship between amino acids, MTOR sig-
naling and autophagy is the subject of this review. The
mechanisms responsible for the stimulation of MTOR-
mediated signaling, and the inhibition of autophagy, by
amino acids have been studied intensively in the past but
are still not completely clarified. Recent developments in
this field are discussed.
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Introduction
For maintenance of cellular homeostasis, it is not only
essential that cell components are synthesized and assem-
bled when required but also that these components are
removed and degraded when they are aberrantly synthe-
sized, become damaged or when they are functionally
redundant. When these processes are not carried out
properly, the cell may either die or turn into a tumor cell in
which cell growth proceeds unrestrained.
The major protein degradation systems include the
ubiquitin–proteasome pathway (responsible for the quality
control of newly synthesized proteins and the degradation
of short-lived proteins) (Ciechanover 2012), macroauto-
phagy (responsible for the degradation of long-lived pro-
teins, protein aggregates and entire organelles) (Klionsky
and Codogno 2013; Choi et al. 2013; Shen and Mizushima
2014) and chaperone-mediated autophagy (taking care of
the removal of specific cytosolic proteins carrying a lyso-
somal target motif) (Cuervo and Wong 2014). Cross talk
between these systems is also possible (Wang et al. 2013).
The process of macroautophagy (hereafter referred to as
‘‘autophagy’’) has gained tremendous scientific interest in
recent years. This is not only because of the partial
unraveling of the protein and lipid machinery participating
in this complicated cell biological process (Ohsumi 2014;
Feng et al. 2014) but also because of the control of auto-
phagic flux by growth factor- and amino acid-dependent
signal transduction (Meijer and Codogno 2009; Russell
et al. 2014). Above all, however, autophagy gained general
interest because dysregulation of the process is implicated
in many pathologies. These include, for example, cancer,
neurodegeneration, obesity, type 2 diabetes, aging, heart
and liver disease, lysosomal storage disorders, bacterial/
viral infection and immunity diseases (Rubinsztein et al.
2012; Lavallard et al. 2012; Lieberman et al. 2012; Lorin
et al. 2013a; Jiang and Mizushima 2014). In addition,
autophagic activity in neurons of the hypothalamus appears
to play an essential role in the control of body energy
expenditure, appetite and body weight (Kaushik et al.
2011; Lavallard et al. 2012; Quan and Lee 2013). After a
brief description of the process of autophagy as we know it
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today, the focus in this review will be on the regulation of
autophagy by amino acids. The history of this fascinating
topic, the discovery of amino acid-dependent signaling and
possible mechanisms contributing to the inhibition of
autophagy by amino acids, with recent developments in
this field, will be discussed.
Autophagy
According to current opinion, the primary function of
autophagy is to allow the cell to survive under stress
conditions rather than to function as a cell death mecha-
nism (Kroemer and Levine 2008). In the course of
autophagy, macromolecules are degraded to small mole-
cule precursors in order to support essential metabolic
pathways under these conditions. A classical example at
the whole body level is the autophagic production of amino
acids, in the liver or elsewhere in the body, for hepatic
gluconeogenesis during starvation (Schworer and Morti-
more 1979; Ueno et al. 2012), glucose being essential as
energy source for brain and erythrocytes under all
circumstances.
During autophagy, which occurs in all eukaryotic cells,
part of the cytoplasm is surrounded by a double membrane
to form an autophagosome that acquires hydrolytic
enzymes by fusion with endocytic compartments and
lysosomes to form an autophagolysosome. In this process,
the outer autophagosomal membrane fuses with the lyso-
somal membrane, and the inner autophagosomal membrane
vesicle is released in the lysosomal lumen ((Meijer and
Codogno 2009), for literature) upon which this vesicle,
including its sequestered material, becomes degraded. The
degradation products (e.g., amino acids) are transported to
the cytosol via specific permeases (Mizushima and Klion-
sky 2007). The rate-limiting step in the entire autophagic
pathway is the formation of the autophagosome. This for-
mation starts with the expansion of a membrane core, the
isolation membrane, or so-called phagophore (Seglen and
Bohley 1992; Klionsky and Seglen 2010). Although pro-
gress concerning the origin and the biogenesis of the iso-
lation membrane has been made, many questions still
remain to be answered (Lamb et al. 2013; Shibutani and
Yoshimori 2014). Very recent data suggest that the
phagophore may be built up from the ER-mitochondria
contact site (Hamasaki et al. 2013). However, other com-
partments such as the endoplasmic reticulum-Golgi inter-
mediate compartment (Ge et al. 2013), endosomes and the
plasma membrane also contribute to the formation of
autophagosomes (Puri et al. 2013). Many different proteins
are involved in autophagosome formation. More than 30
proteins have been identified in yeast (Ohsumi 2014; Feng
et al. 2014) which are referred to as ATG (Autophagy
related) proteins. Seventeen of these proteins are engaged
in the biogenesis of the autophagosome, most of which are
conserved in mammalian cells (including human cells) but
carry different names in order to distinguish them from
their yeast counterparts (Stanley et al. 2014). Among these
is LC3-I (equivalent to Atg8 in yeast) which, when lipi-
dated with phosphatidylethanolamine (and then named
LC3-II), is widely used as a marker of autophagosomes
(Klionsky et al. 2012).
Autophagosome formation and degradation can be
extremely rapid. For example, in rat hepatocytes in vivo,
the autophagic sequestration rate may vary from 0.2 % in
the fed state to 1–1.5 % of the cell volume/h in the fasted
state (Schworer and Mortimore 1979; Kovacs et al. 1982).
In vitro, with isolated hepatocytes or in the perfused liver,
in the absence of amino acids, this rate can be as high as
4 %/h (Blommaart et al. 1997a).
In the liver, autophagosomes are synthesized and
degraded with a half-life of 8 min (Pfeifer 1977, 1978;
Schworer and Mortimore 1979), and such short half-lives
also apply to other cell types (Hailey and Lippincott-Sch-
wartz 2009; Shibutani and Yoshimori 2014). Because of
this high turnover rate, the steady-state volume of auto-
phagosomes in the cell is low. It is important to stress that
the measurement of the steady-state level of autophago-
somes (a situation to be compared with the concentration of
an intermediate in a metabolic pathway) does not give any
information on the magnitude of the autophagic flux as is
often assumed, and this notion not only applies to hepa-
tocytes but to other cells as well (Meijer 2009; Klionsky
et al. 2012). In order to estimate autophagic flux, at least
for in vitro studies with perfused organs or cultured cells,
several methods have been recommended. Among these,
the most popular are the rate of 3-methyladenine (an
inhibitor of autophagosome formation, see below)-sensi-
tive degradation of long-lived proteins and the rate of
accumulation of LC3-II (not the level of LC3-II at one time
point), which is assumed to represent the rate of auto-
phagosome formation, when lysosomal function and/or
fusion is compromised by specific inhibitors (e.g., by
chloroquine or bafilomycin, respectively) (Klionsky et al.
2012). The latter method may be complicated by possible
feedback interactions caused by the accumulation of
autophagosomes (Ktistakis et al. 2011) so that the accu-
mulation of LC3-II may not always be linear with time.
Another approach to quantify autophagic flux measures the
rate of disappearance of p62/SQSTM1, an adapter protein
that serves to carry protein cargo to be degraded to the
phagophore (Bjorkoy et al. 2009). However, caution must
be taken because in some cell lines amino acids upregulate
the transcription of SQSTM1 (Sahani et al. 2014). Other
methods, including sophisticated fluorescence techniques,
are also available. For a complete description of these
Regulation of autophagy by amino acids 2039
123
Fig. 1 Overview of the autophagic machinery. (Macro)autophagy
starts with the nucleation of an isolation membrane, named the
phagophore, which surrounds a fraction of the cytoplasm destined for
degradation. Upon induction of autophagy, e.g., in starvation, the
ULK1 complex localizes to a specialized domain of the ER called the
omegasome. This privileged site for the biogenesis of the phagophore
forms a cradle where the autophagosomal membrane elongates and
acts as a template for the spherical form of the autophagosome.
Downstream the ULK1 complex is the PIK3C3 complex, which
produces phosphatidylinositol 3-phosphate (PI(3)P) to allow the
recruitment of the PI(3)P-binding proteins WIPI1/2 and ZFYVE1/
DFCP1. Both contribute to the expansion and the closure of the
autophagosome together with the ATG12–ATG5-ATG16L complex
and the LC3-phosphatidylethanolamine (LC3-PE) conjugate.
Whereas ATG12–ATG5-ATG16L only transiently associates with
the autophagosomal membrane, LC3–PE constitutes a specific marker
of the autophagosome as it remains associated with the autophagos-
omal inner membrane. The newly formed autophagosome receives
input from the endocytic pathway and ultimately fuses with a
lysosome, allowing the degradation of autophagic substrates by
lysosomal hydrolases. Fusion of the autophagosome with the
lysosome requires the small Rab GTPases (such as Rab7, 8B and
24) and the transmembrane lysosomal protein LAMP2. The products
of autophagic degradation, such as amino acids, are recycled to the
cytosol where they exert a negative feedback on autophagy initiation.
In addition to amino acids, autophagy is also controlled by upstream
signaling pathways governed by insulin/growth factors, reactive
oxygen species (ROS) and the energy status (through AMPK). Most
of these factors regulate the two initiation complexes, ULK1 and
PIK3C3. As a master regulator of autophagy, MTORC1 integrates
multiple of these upstream signals and controls the activity of the
ULK1 complex
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techniques, the reader is referred to a recent paper
(Klionsky et al. 2012).
Autophagy is initiated by activation of a protein com-
plex containing the protein kinases ULK1 and 2 (the
mammalian counterpart of yeast Atg1), the proteins
ATG13, FIP200 (yeast Atg17), ATG101 and many other
components (Wong et al. 2013; Russell et al. 2014).
Phosphorylation of ATG13 by ULK1/2 promotes the
association of these proteins and is essential for initiation
of autophagy (Fig. 1). ULK1 binds to membranes through
its C-terminal domain (Chan et al. 2009). Downstream of
the ULK1/2 complex is a lipid kinase, PIK3C3 (yeast
Vps34), which produces PI(3)P and which is part of
another protein complex also containing the regulatory
protein PIK3R4 (yeast Vps15), the proteins Beclin1 (yeast
Atg6/Vps30), ATG14 (also known as BARKOR). In the
Beclin1-PIK3C3 core complex, Beclin1 can interact with
several proteins such as AMBRA1, UVRAG and VMP1 to
control autophagosome formation and/or maturation (Wirth
et al. 2013) (cf. also Fig. 2). ULK1 phosphorylates both
AMBRA1 and Beclin1 to initiate autophagosome forma-
tion (Russell et al. 2013; Lorin et al. 2013a). This results in
activation of PIK3C3. Production of PI(3)P recruits PI(3)P-
binding proteins involved in the initial formation of the
autophagosome, WIPI1/2 (yeast Atg18), ZFYVE1/DFCP1
and two ubiquitin-like conjugation systems ATG12–
ATG5-ATG16L and LC3-phosphatidylethanolamine
(LC3-II) (Polson et al. 2010; Weidberg et al. 2011; Mc-
Alpine et al. 2013). PI(3)P is also required to join the ends
of the autophagosomal membrane in statu nascendi (termed
the ‘‘omegasome’’ because of its cup-formed shape) (Axe
et al. 2008). The final fusion of the newly formed auto-
phagosome with the lysosome requires small Rab GTPases,
such as Rab7, Rab8 and Rab24, and the transmembrane
protein LAMP2 (Simonsen and Tooze 2009; Ao et al.
2014).
Association of Beclin1 with PIK3C3 is an essential step
in autophagosome formation. However, Beclin1 is a BH3
(Bcl-2 homology domain) protein and can also associate
with the anti-apoptotic proteins Bcl-2/Bcl-xL which con-
tain a BH3-binding groove. This means that association of
Beclin1 with these anti-apoptotic proteins is inhibitory for
autophagy and their dissociation is essential to allow Be-
clin1 to bind to PIK3C3 and to initiate autophagy. The
dissociation of the inhibitory Beclin1–Bcl-2 complex is
promoted by either JNK-1-mediated phosphorylation of
Bcl-2, by phosphorylation of Beclin1 mediated by the
tumor suppressor DAPK (a Ca2?-calmodulin-activated
protein kinase), or by displacement of Beclin1 from its
complex with Bcl-2 by other BH3-containing proteins such
as the proapoptotic protein BAD and the proautophagic
protein BNIP3 ((Meijer and Codogno 2009; Marin˜o et al.
2014a), for literature) (Fig. 2).
The insulin-amino acid-MTOR signaling pathway
The initiation of autophagosome formation is controlled
by the insulin/growth factor-PI3KC1-PKB-TSC-MTOR-
mediated signal-transduction pathway, which integrates
hormonal, nutritional, cellular energy and oxidative
stress inputs and which controls all major metabolic
pathways (Meijer and Codogno 2009; Avruch et al.
2009; Kim and Guan 2011; Laplante and Sabatini 2012;
Shanware et al. 2013; Cornu et al. 2013; Kim et al.
2013b).
The initial part of this signaling pathway, upstream of
MTOR, an evolutionary conserved serine/threonine protein
kinase which was first described by (Heitman et al. 1991),
involves the insulin receptor, IRS1 and IRS2, PIK3C1,
producing PI(3,4,5)P3 and PI(3,4)P2, PDK1 and PKB
(Fig. 2). For activation of MTOR, the presence of insulin
alone is not sufficient: The presence of amino acids is
indispensable (Blommaart et al. 1995; Hara et al. 1998;
Meijer and Codogno 2009; Barazzoni et al. 2012) (see
below).
The second part of the insulin-signaling pathway,
downstream of MTOR, may involve components such as
S6K, 4E-BP1, eIF2a kinase and eEF2 kinase. Phosphory-
lation of these proteins by MTOR promotes protein
synthesis.
MTOR itself is part of two multiprotein complexes.
MTORC1 contains MTOR, RAPTOR, mLST8, and the
inhibitory proteins DEPTOR and PRAS40. MTORC2
(not indicated in Fig. 2) contains MTOR, RICTOR,
mLST8, mSin1, PROTOR and DEPTOR. Activation of
MTORC1 simultaneously inhibits autophagy and stimu-
lates protein synthesis (Meijer and Codogno 2009; Lap-
lante and Sabatini 2012). Activation of MTORC2 does
not have these effects but rather phosphorylates, and
activates, PKB. In liver, for example, this results in
stimulation of glycolysis and lipid biosynthesis (Hagiw-
ara et al. 2012). MTORC1 and MTORC2 can be distin-
guished on the basis of their sensitivity toward inhibition
by rapamycin which only inhibits MTORC1 (Sarbassov
et al. 2006). Although the kinase activity of MTOR in
MTORC2 is insensitive to acute rapamycin treatment,
chronic exposure to the drug can disrupt its structure and
results in insulin resistance (Sarbassov et al. 2006; Ye
et al. 2012).
The activity of MTOR in MTORC1 is inhibited by the
heterodimer TSC1/TSC2: it acts as a GTPase-activating
protein complex for the small G-protein Rheb. RhebGTP,
not RhebGDP, binds and activates MTOR. PKB phos-
phorylates TSC2, which inactivates the TSC1/TSC2
complex and stimulates MTORC1 (Fig. 2). In addition,
MTORC1 is stimulated by PKB-dependent phosphory-
lation of PRAS40 (Manning and Cantley 2007).
Regulation of autophagy by amino acids 2041
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Interaction of the insulin-amino acid-MTOR signaling
pathway with autophagy
The insulin/growth factor-PIK3C1-PKB-MTOR signaling
pathway inhibits autophagosome formation at several
levels.
MTOR phosphorylates ULK1/2 and ATG13 which
results in their dissociation and in inactivation of ULK
(Ganley et al. 2009; Jung et al. 2009; Mizushima and
Komatsu 2011; Lorin et al. 2013a). MTOR also inactivates
PIK3C3, albeit indirectly, i.e., when the lipid kinase is
associated with ATG14, by phosphorylating ATG14 (Yuan
et al. 2013). Long-term regulation of autophagy by MTOR
occurs by phosphorylation of the transcription factor EB
(TFEB), a master regulator of the synthesis of ATG pro-
teins and of the biogenesis of lysosomes. This phosphor-
ylation prevents translocation of TFEB to the nucleus
(Settembre et al. 2012). In addition, the activity of TFEB is
inhibited by nutrient- and growth factor-dependent extra-
cellular signal-regulated kinase 2 in an MTOR-independent
fashion (Settembre et al. 2011) (Fig. 2). The same protein
kinase can also inhibit autophagy in the short term by
phosphorylation of TSC1/TSC2 (Kim et al. 2013b).
The complexity of the regulation of autophagy byMTOR
is illustrated by the fact that MTOR not only inhibits ULK1
but that, conversely, ULK1 also inhibits MTOR by phos-
phorylation. This inhibition of MTORC1 by ULK1 may
serve to amplify and stabilize initially small changes in
nutrient signaling (Chang et al. 2009; Jung et al. 2011).
Autophagy is also controlled by PKB. Short-term regu-
lation occurs by PKB-dependent phosphorylation of Beclin1
(Wang et al. 2012) (Fig. 2). Long-term regulation by PKB
occurs by phosphorylation of FoxO3, another transcription
factor responsible for the synthesis of ATG proteins
(Mammucari et al. 2007). This set of ATG proteins differs
from that controlled by TFEB (Settembre et al. 2011).
In addition to these various phosphorylation mecha-
nisms, PI(3,4,5)P3 and PI(3,4)P2, the products of PIK3C1,
are inhibitors of autophagy, possibly because these lipids
compete with PI(3)P (Petiot et al. 2000; Meijer and Cod-
ogno 2009; Farrell et al. 2013).
Regulation of autophagy by amino acids and hormones:
some history
Initial studies on the regulation of autophagy were primarily
carried out with liver, both in vitro with the perfused liver
and isolated hepatocytes, and in vivo. The process was
known to be product inhibited by amino acids (Schworer
cFig. 2 Regulation of autophagy by amino acids. Autophagosome formation is regulated by two major modulators of autophagy, the MTORC1
and PIK3C3 complexes, which integrate amino acid signaling. Under fed conditions, when MTORC1 is fully active, MTORC1 downregulates
autophagy by phosphorylating ULK1 and ATG13, which inhibits the ULK1 complex. MTORC1 also inhibits the synthesis of ATG proteins and
the synthesis of proteins involved in the biogenesis of lysosomes at the transcription level, by preventing the translocation of TFEB to the
nucleus. MTORC1 is activated in two ways: first, by insulin/growth factor signaling which involves PIK3C1, PDK1, PKB and TSC1/TSC2 as
signaling components, and second, by amino acids through the Rag GTPases. To be active, MTORC1 has to localize at the lysosomal membrane,
where its co-activator RhebGTP resides. In response to amino acids, Rag promotes the translocation of MTORC1 to the lysosomal membrane and
its consecutive activation. Rag proteins are heterodimers of two subunits: RagA/B and RagC/D in which RagA/B is linked to GTP and RagC/D to
GDP in the most active form of the dimer. The Rag GTPases are regulated by the v-ATPase, Ragulator and leucyl-tRNA synthetase (LRS). The
nucleotide status of RagA/B and of RagC/D is regulated by GATOR and folliculin, respectively (not shown in the figure, for the purpose of
clarity; see main text). In response to a rise in the intralysosomal pool of amino acids, the v-ATPase, present in the lysosomal membrane, changes
its conformation and recruits Ragulator which displays a guanine nucleotide exchange factor (GEF) activity toward RagA/B. This results in the
formation of RagA/BGTP and the activation of MTORC1. In this mechanism, the transporter PAT1, responsible for the efflux of amino acids from
the lysosome, controls the concentration of amino acids in the lysosomal lumen and thus the extent of MTORC1 activation. In the presence of
cytosolic leucine, binding of leucine to LRS reveals its GTPase-activating protein (GAP) activity toward RagC/D, resulting in the formation of
RagC/DGDP and activation of MTORC1. The activity of Rag is also promoted by glutamate dehydrogenase (GDH). This mitochondrial enzyme,
which plays a central role in amino acid catabolism, is allosterically activated by leucine. The production of 2-oxoglutarate by GDH may
stimulate the loading of RagB with GTP. GDH may also activate MTORC1, and inhibit autophagy, through other distinct mechanisms. (1) The
production of NAD(P)H by GDH may lead to the reduction of ROS, a potent activator of autophagy which acts through MTORC1-dependent and
MTORC1-independent pathways (i.e., by inhibiting MTORC1 and PKB and by activating AMPK and ATG4). In addition to NAD(P)H,
2-oxoglutarate can also act as a scavenger of ROS, which oxidizes 2-oxoglutarate to succinate non-enzymatically. (2) The production of
2-oxoglutarate by GDH replenishes the citric acid cycle intermediates, increases the rate of ATP production and inhibits AMPK. The fall in
AMPK activity may inhibit autophagy by MTORC1-dependent and MTORC1-independent mechanisms (i.e., by inhibition of TSC1/TSC2,
stimulation of MTORC1 and inhibition of the ULK1 complex and of Beclin1). Probably acting in parallel with the Rag GTPase pathway,
MAP4K3 and IPMK are other proteins involved in the regulation of MTORC1 by amino acids. The extracellular pool of amino acids may be
sensed by the plasma membrane amino acid receptor T1R1/T1R3, which regulates MTORC1 and autophagy. The other major protein complexes
controlling autophagy contain the Beclin1 protein. The core proteins of these two complexes are Beclin1, PIK3C3 and PIK3R4. When associated
with ATG14 and AMBRA1, Beclin1 stimulates the early steps of autophagosome formation, downstream of the ULK1 complex. When
associated with UVRAG, Beclin1 is mainly involved in the formation and maturation of autophagosomes. In response to amino acids, the protein
kinase JNK1 becomes inhibited, leading to the formation of a stable complex between Beclin1 and Bcl-2 which sequesters Beclin1 and results in
inhibition of autophagy. Beclin1 is also inhibited by PKB-dependent phosphorylation, which likewise inhibits autophagy. Long-term regulation
of autophagy by PKB occurs by phosphorylation of FoxO3, another transcription factor (in addition to TFEB) responsible for the synthesis of
ATG proteins. For further details, see main text. For reasons of clarity, the control of the inhibitory acetylation of ATG proteins by mitochondrial
amino acid catabolism, which increases the concentration of acetyl CoA in the cytosol, is not indicated in the figure
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and Mortimore 1979; Seglen et al. 1980), stimulated by
glucagon (Ashford and Porter 1962; Deter et al. 1967) and
inhibited by insulin (Mortimore and Mondon 1970), but the
mechanisms underlying these effects were unknown at the
time. Interestingly, in the perfused liver insulin and gluca-
gon did only affect autophagy at intermediate amino acid
concentrations but had no effect in the absence of amino
acids when autophagic flux was maximal, nor did they have
an effect in the presence of high concentrations of amino
acids that inhibited autophagy maximally (Schworer and
Mortimore 1979; Mortimore et al. 1987). It was also clear
that regulation of autophagy by these factors was primarily
exerted at the level of autophagosome formation (the
autophagic sequestration step), although effects at later
stages in the autophagic pathway could not be excluded
(Hoyvik et al. 1991; Luiken et al. 1996). One confounding
factor in experiments in vitro has been the accumulation of
ammonia, derived from amino acid degradation which was
found to increase the intralysosomal pH because of its ac-
idotropic properties (Seglen 1977; Kadowaki and Kanaza-
wa 2003). Even today, this complication is not always
appreciated and unawareness of it may lead to erroneous
conclusions (Meijer 2009).
Our own interest in the regulation of autophagy by
amino acids was triggered by experiments performed with
freshly isolated, perifused, rat hepatocytes under true
steady-state conditions. Intriguingly, we found that a sim-
ple combination of leucine and alanine (which was selected
on the basis of existing literature) at near-physiological
concentrations could mimic the inhibitory effect on auto-
phagic proteolysis of a complete mixture of all amino acids;
either alanine or leucine alone had no effect (Leverve et al.
1987). Similar observations were made by Mortimore and
colleagues for the perfused liver (Mortimore et al. 1988).
Regulation of autophagy by amino acids 2043
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Combinations of low concentrations of leucine and either
proline, glutamine, or asparagine were also effective as
inhibitors of autophagy (Caro et al. 1989). With leucine
present, the inhibition by alanine, but not by proline, glu-
tamine, or asparagine, was sensitive to inhibition by amino-
oxyacetate, a transaminase inhibitor (Leverve et al. 1987;
Caro et al. 1989). This indicated that metabolism of alanine,
but not that of leucine, was required for its inhibitory effect
on autophagy. As conversion of proline and glutamine to
glutamate and of asparagine to aspartate does not require
transamination reactions, we suspected that a combination
of leucine with intracellular glutamate or aspartate (which
does not readily leave hepatocytes) was sufficient to inhibit
autophagy maximally. Indeed, in the presence of leucine
and either alanine, proline, glutamine, or asparagine, there
was an inverse relationship between the rate of autophagic
proteolysis and the intracellular concentration of glutamate
plus aspartate (Caro et al. 1989). However, the underlying
mechanism for the inhibition of autophagy was entirely
unknown. Interestingly, the same amino acids that inhibited
hepatic autophagic proteolysis were also known to inhibit
proteolysis in other tissues, including skeletal muscle, heart
and kidney, with leucine being most effective (Blommaart
et al. 1997a).
A new factor in the control of autophagic protein deg-
radation was introduced with the observation, initially
reported for liver but later extended to other cell types, that
an increase in cell volume was able to mimic several of the
anabolic properties of insulin, including inhibition of gly-
cogenolysis (Lang et al. 1989), inhibition of proteolysis
(Hallbrucker et al. 1991), stimulation of protein synthesis
(Stoll et al. 1992) and lipogenesis (Baquet et al. 1991). Cell
swelling was induced by either hypo-osmotic conditions or
by Na?-dependent concentrative transport of amino acids
across the plasma membrane. We suspected that intracel-
lular accumulation of impermeant metabolites such as
glutamate and aspartate, derived from amino acid degra-
dation, also helped to increase the intracellular osmolarity
and in this way contributed to cell swelling. In freshly
isolated hepatocytes, cell swelling was found to mimic the
effect of insulin in that it potentiated the ability of a
complete mixture of amino acids, or of a combination of
leucine with tyrosine and phenylalanine, to inhibit auto-
phagic proteolysis (Meijer et al. 1993; Luiken et al. 1994).
Around the same time, our group in Amsterdam, in
collaboration with the group of Hue in Brussels, studied the
mechanism of the stimulation by amino acids of glycogen
synthesis from glucose. This stimulation, first reported by
Katz and colleagues (Katz et al. 1976), had been investi-
gated by many laboratories but its mechanism was never
elucidated. We discovered that the synthesis of glycogen,
too, was due to an amino acid-induced increase in cell
volume (Baquet et al. 1990). Leucine, which did not
increase cell volume, had no effect, indicating that the
mechanism of the stimulation of glycogen synthesis by
amino acids differed from that of their inhibition of
autophagy. It was known at the time that, in response to an
increase in cell volume, cells undergo ‘‘regulatory volume
decrease’’ in which they try to restore, at least in part, the
original volume by releasing KCl (Hoffmann and Simon-
sen 1989; Ha¨ussinger 1996). We then found that the
enzyme glycogen synthase phosphatase was inhibited by
intracellular chloride and that the fall in chloride in
response to cell swelling was sufficient to activate this
enzyme and thus the synthesis of glycogen (Meijer et al.
1992). With regard to autophagy, the mechanism of inhi-
bition by cell swelling was, and still is, not clear. Perhaps
chloride ions are involved because they accompany pro-
tons, driven by the ATP-dependent lysosomal proton
pump, to the lysosomal interior (Ishida et al. 2013). Very
recent evidence suggests that this may, indeed, be the case
(Hosogi et al. 2014). An effect of cell swelling on the
cytoskeleton, mediated by integrins, is another, or addi-
tional, possibility (Ha¨ussinger et al. 2006).
In summary, in the control of autophagy, leucine
appeared to be the most inhibitory amino acid. In addition,
its anti-proteolytic effect was potentiated by insulin and by
cell swelling.
Discovery of amino acid signaling and its relationship
with autophagy
Early studies by Seglen and coworkers with protein kinase
and protein phosphatase inhibitors indicated that protein
phosphorylation was involved in the regulation of
autophagy in hepatocytes, but the connection with amino
acids was not made (Holen et al. 1992, 1993).
A breakthrough in our understanding of the mechanism
by which amino acids inhibit autophagy (and stimulate
protein synthesis) was obtained by the Amsterdam group in
a study carried out with [32P]Pi-labeled rat hepatocytes. It
was discovered that the same amino acid mixtures that
inhibited autophagy greatly stimulated (up to fivefold) the
phosphorylation of a protein that was identified as ribo-
somal protein S6, with rapid kinetics (t1/2, 10 min). The
stimulation of S6 phosphorylation by amino acids was not
due to the inhibition of a protein phosphatase acting on S6
(Luiken et al. 1994; Blommaart et al. 1995). Dephospho-
rylation of S6 followed similar rapid kinetics upon with-
drawal of amino acids or by addition of rapamycin. We
observed synergy between either insulin or cell swelling
and low concentrations of a complete mixture of amino
acids, not only with regard to their inhibition of autophagic
proteolysis but also with regard to their ability to promote
S6 phosphorylation. Addition of insulin alone, in the
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absence of added amino acids, did not stimulate S6 phos-
phorylation. In the presence of high concentrations of
amino acids, S6 phosphorylation was maximal and not
further increased by insulin. Glucagon, on the other hand,
stimulated autophagy and inhibited S6 phosphorylation at
low, but not at high concentrations of amino acids or in
their absence. Among various amino acids, leucine, not
valine, appeared to be very effective. Under several incu-
bation conditions, with different amino acid mixtures, in
the absence or presence of insulin and glucagon, there
appeared to be a linear relationship between the percentage
of inhibition of autophagic proteolysis (measured in the
presence of a low concentration cycloheximide sufficient to
inhibit simultaneous protein synthesis) and the degree of
phosphorylation of S6 (Blommaart et al. 1995). Amino
acid-induced S6 phosphorylation was completely pre-
vented by rapamycin, indicating that MTOR and S6K were
components of the signaling pathway. Of great significance
was the fact that rapamycin could partly (albeit not com-
pletely, this will be explained later) reverse the inhibition
of autophagy by amino acids. It should be stressed, how-
ever, that in the absence of cycloheximide, rapamycin also
did not completely inhibit protein synthesis. Because at
that time MTOR signaling was known to be involved in the
regulation of protein synthesis, it was concluded that
(global) protein synthesis and (autophagic) protein degra-
dation were under the opposite control by the same sig-
naling pathway, which was considered to be metabolically
efficient (Blommaart et al. 1995).
These studies were the first to demonstrate that amino
acids were essential for MTOR-mediated signaling and that
this signaling was connected to the regulation of autoph-
agy. They were also the first demonstration that rapamycin
was able to stimulate autophagy.
The stimulation of autophagy by rapamycin was con-
firmed several years later for other cell types (Mordier et al.
2000; Eskelinen et al. 2002; Moazed and Desautels 2002),
including yeast (Noda and Ohsumi 1998), and rapamycin is
nowadays widely used as an activator of autophagy (Ru-
binsztein et al. 2012). Torin1, a newly developed ATP-
competitive inhibitor of MTOR, acts similarly (Thoreen
et al. 2009).
The ability of amino acids to stimulate signaling even in
the absence of insulin, and the synergy of amino acids with
insulin, was confirmed for hepatocytes (Krause et al. 1996)
and for other insulin-sensitive cell types, including muscle
cells, adipocytes, hepatoma cells, CHO cells and pancreatic
b-cells (Hara et al. 1998; Wang et al. 1998; Fox et al. 1998;
Patti et al. 1998; Xu et al. 1998; Iiboshi et al. 1999). In
these studies, it was shown that, in addition to S6, other
downstream targets of MTOR such as S6K, 4E-BP1, eIF2a
kinase (the equivalent of Gcn2 in yeast) and eEF2 kinase
were found to be phosphorylated in response to amino
acids. However, these studies also indicated that amino
acids did not affect PKB activity and PIK3C1, signaling
proteins upstream of MTOR that were known to be stim-
ulated by insulin. It was also demonstrated that in case
insulin alone, in the absence of added amino acids, stim-
ulated MTOR signaling, this was dependent on the pre-
sence of amino acids that were generated by autophagic
proteolysis (Shigemitsu et al. 1999a; Beugnet et al. 2003;
Duran et al. 2011). Noteworthy is that the kinetics of the
stimulation by amino acids of MTOR-mediated phospho-
rylations in these various cell types were similar to those
observed by Blommaart et al. (1995) with regard to S6
phosphorylation in hepatocytes. They were also similar to
the rapid phosphorylations reported very recently in an
extensive study on the early temporal dynamics of the
phosphoproteome in breast cancer cells upon initiation of
autophagy by either withdrawal of amino acids or by
addition of rapamycin (Rigbolt et al. 2014).
Most studies agreed that leucine (but not the other bran-
ched-chain amino acids), independent of the cell type, was
the most effective amino acid in stimulating signaling but
that, in addition, some other amino acidswere required (Hara
et al. 1998;Wang et al. 1998; Fox et al. 1998; Patti et al. 1998;
Xu et al. 1998; Kimball et al. 1999; Shigemitsu et al. 1999b;
van Sluijters et al. 2000; Lynch et al. 2000; Atherton et al.
2010). In analogy with the inhibition of autophagy and the
stimulation of S6 phosphorylation by amino acids (see
above), it was proposed that leucine, in combination with
amino acid-induced cell swelling, would be sufficient to
stimulate signaling (van Sluijters et al. 2000). In line with
this, Krause et al. (2002b) showed synergy between gluta-
mine, a potent amino acid in promoting cell swelling, and
leucine with regard to S6K phosphorylation in hepatocytes.
In intestinal cells, with their rapid growth, in addition to
glutamine and leucine, arginine has also been mentioned as
an activator of MTOR signaling (Nakajo et al. 2005; Marc
and Wu 2009). In CHO cells, arginine also stimulated sig-
naling albeit less effective than leucine (Hara et al. 1998).
Although never considered, it is possible that the effect of
arginine may be attributed, at least in part, to glutamate
produced from arginine by the combined actions of arginase,
ornithine aminotransferase and pyrroline 5-carboxylate
dehydrogenase. Involvement of NO production from argi-
nine can also not be excluded (Angcajas et al. 2014).
In order to account for the synergy between amino acids
and insulin with respect to the activation of MTOR, it had
to be assumed that MTOR received two parallel input
signals, one from the insulin-PIK3C1-PKB signaling
branch and one from amino acids (cf. (van Sluijters et al.
2000; Shah et al. 2000), for reviews). We now know that
this is, indeed, the case (cf. Fig. 2): Insulin activates
MTOR through PKB-dependent phosphorylation of TSC2,
which results in activation of Rheb, and of PRAS40 as
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discussed earlier, while amino acids separately activate
MTOR by mechanisms to be discussed below. However,
the relative contribution of insulin and amino acids in the
regulation of MTORC1 and autophagy may be tissue
dependent. Thus, in mice in vivo, insulin appeared to be
more potent in stimulating MTORC1 and inhibiting
autophagy in muscle than in liver. By contrast, amino acids
were more potent in the control of MTORC1 and autoph-
agy in the liver than in muscle (Naito et al. 2013). This
difference between the two tissues was tentatively ascribed
to the regulation of MTORC1 and of autophagy by glu-
cagon in the liver, but not in muscle. Another possibility is
that there are differences in the intramuscular and intra-
hepatic amino acid concentrations.
S6K was also shown to phosphorylate, and inhibit, IRS1
(Tremblay and Marette 2001). Although this feedback
effect of S6K has been proposed to participate in the eti-
ology of insulin resistance (Um et al. 2004; Efeyan et al.
2014), it may also act as a mechanism to prevent overac-
tivation of the MTOR pathway in order to allow some
autophagy to continue even under nutrient-rich conditions
(Meijer and Codogno 2009).
The inhibition of MTOR signaling by glucagon was
later shown to proceed through a mechanism dependent on
protein kinase A (Kimball et al. 2004), which stimulates
autophagy (Mavrakis et al. 2006). It must be pointed out
that, in contrast to mammalian cells, activation of protein
kinase A in yeast cells inhibits autophagy (Stephan et al.
2009). In this context, it is important to stress that the
function of cAMP in yeast, in contrast to that in mamma-
lian cells, is to stimulate cell growth (Thevelein and de
Winde 1999).
The requirement of PI(3)P for autophagy
Although in the presence of amino acids, rapamycin was
able to stimulate autophagy, interruption of signaling by
the PIK3C1 inhibitors wortmannin and LY294002, unex-
pectedly, did not. Even more surprising was the finding that
in the absence of amino acids, with maximal autophagic
flux, these two compounds strongly inhibited autophagy
(Blommaart et al. 1997b). At the time, mammalian cells
were known to contain both PIK3C1 and PIK3C3 while
yeast only contained the homolog of PIK3C3, Vps34 (and
its adapter protein Vps15). Vps34 was known to be
involved in processes requiring membrane flow (Schu et al.
1993), but its relationship with autophagy was not yet
studied in this organism. Because the phosphatidylinositol
3-kinase inhibitors wortmannin and LY294002 were not
specific in that they could not distinguish between PIK3C1
and PIK3C3, it was postulated that perhaps PIK3C3, and
thus its product PI(3)P, might be essential for autophagy
(Blommaart et al. 1997a, b). This hypothesis was tested,
and confirmed, in transfection experiments using HT-29
cells, a human colon cancer cell line, which showed that
PI(3)P was, indeed, required for autophagy. Moreover, the
products of PIK3C1, PI(3,4)P2 and PI(3,4,5)P3 acted as
inhibitors of autophagy (Petiot et al. 2000). In further
support of this, it was found that overexpression of PTEN,
which removes the phosphate from the 3-position of
PI(3,4)P2 and PI(3,4,5)P3, increased autophagy (Arico
et al. 2001).
These observations were the first to show that PI(3)P
participated in the process of autophagy. They have been
amply confirmed for both mammalian cells and yeast
(Kihara et al. 2001; Suzuki et al. 2001; Jaber et al. 2012;
Schink et al. 2013; Cheng et al. 2014).
3-Methyladenine
An important spin-off from these studies was our finding
that 3-methyladenine, a specific inhibitor of autophagy
described by Gordon and Seglen in as early as 1982 (Se-
glen and Gordon 1982), and which has proven to be
extremely useful in studies on autophagy (to this day),
turned out to be an inhibitor of PIK3C3. This provided a
satisfactory explanation for its mechanism of action
(Blommaart et al. 1997b; Petiot et al. 2000).
Autophagy regulation and energy: the role of AMPK
Apart from being activated by insulin and amino acids,
MTOR was also found to be affected by the cellular energy
state. Initial studies with HEK293 cells indicated that
MTOR may also act as a sensor of the intracellular ATP
concentration (Dennis et al. 2001). It was noted that among
various protein kinases the Km of MTOR for ATP in vitro
was exceptionally high and within the physiological (mM)
range of ATP concentrations. Because intracellular AMP is
much more sensitive than ATP as an indicator of the cel-
lular energy state, being connected to ATP in the reversible
adenylate kinase reaction, AMPK was later considered as
another candidate controlling MTOR activity. Indeed,
studies simultaneously reported by several laboratories,
including our own, demonstrated that, rather than the
decreased ATP concentration, it was the activation of
AMPK that was responsible for the inhibition of MTOR
when energy falls short (Fig. 1) (Dubbelhuis and Meijer
2002; Bolster et al. 2002; Larsen et al. 2002; Krause et al.
2002a; Kimura et al. 2003). In agreement with the notion
that inhibition of MTOR results in stimulation of autoph-
agy (as discussed earlier), and also in line with its function
to stimulate catabolism (Hardie 2007), it was reported, first
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by us (Meley et al. 2006) and later by others (Hoyer-
Hansen et al. 2007; Liang et al. 2007), that AMPK is
essential for autophagy. The activation of AMPK also
underlied the stimulation of autophagy in cerebral (Adhami
et al. 2006) and cardiac ischemia (Matsui et al. 2007).
The mechanism by which AMPK inhibited MTOR was
twofold. The first mechanism proceeded via AMPK-med-
iated phosphorylation, and activation, of TSC2 (Inoki et al.
2003; Corradetti et al. 2004) which catalyzes the conver-
sion of RhebGTP to RhebGDP. The second mechanism
proceeded via phosphorylation, and inactivation, of RAP-
TOR (Gwinn et al. 2008) (Fig. 2).
The stimulation of autophagy by AMPK, however, was
not only through inhibition of MTOR but also occurred by
AMPK-mediated phosphorylation, and activation, of ULK1
(Egan et al. 2011; Kim et al. 2011a). Interestingly, ULK1 is
thus phosphorylated by both MTOR and AMPK, but at
different sites, with opposing effects on ULK1 activity
(Meijer and Codogno 2011). In addition, it was recently
shown that in response to glucose starvation AMPK phos-
phorylates, and activates, Beclin1 provided it is associated
with PIK3C3 and ATG14 (Kim et al. 2013a). Thus, as
ULK1, Beclin1 is phosphorylated at different sites, with
opposing effects: in this case by AMPK (activation) and, as
discussed earlier, by PKB (inhibitory) (Fig. 2).
Inhibition of AMPK activity by amino acids (cf. next
paragraph), and thus inhibition of Beclin1, would account
for an earlier observation showing that amino acids
decreased Beclin1-associated PIK3C3 activity (Tassa et al.
2003). An additional explanation is that amino acids pro-
mote the association between Beclin1 and Bcl-2, and thus
Beclin1 sequestration (Pattingre et al. 2005), through
inhibition of JNK1-mediated phosphorylation of Bcl-2
(Wei et al. 2008).
Yet another mechanism by which AMPK can promote
autophagy may proceed through activation of Sirtuin1,
an NAD-dependent protein deacetylase (Canto et al.
2009; Ruderman et al. 2010). Sirtuin1, which increases
in starvation, is known to stimulate autophagy by
increasing the deacetylation of several ATG proteins
(Lee et al. 2008). In addition, Sirtuin1 stimulates the
deacetylation of FoxO3 which also results in activation
(Canto et al. 2009). Conversely, acetylation of ATG
proteins, which inhibits their activity, is brought about
by the acetyltransferase P300 (also known as EP300)
(Lee and Finkel 2009).
In principle, the inhibition of AMPK by amino acids
would be an attractive mechanism to account for their
ability to inhibit autophagy and to stimulate MTOR
activity. Such an effect of amino acids on AMPK could be
mediated by glutamate dehydrogenase, which plays a
central role in amino acid catabolism and which is known
to be specifically stimulated by leucine, not by the other
branched-chain amino acids (Sener and Malaisse 1980;
Fahien et al. 1990). This enzyme produces 2-oxoglutarate,
replenishes citric acid cycle intermediates and thus helps to
increase the rate of ATP production. Indeed, in many
studies, inhibition of AMPK by amino acids has been
observed (Xiao et al. 2011; Ghislat et al. 2012; Li et al.
2013). This was not always the case, however (Krause et al.
2002a; Kim et al. 2011a; Wauson et al. 2012; Duran et al.
2013; Rahman et al. 2014).
Because metabolism differs among cell types, e.g., with
differences in the use of oxidizable substrates, it is
understandable that the effect of amino acids on AMPK
may vary. Although it is possible that AMPK is involved in
amino acid regulation of autophagy and of MTOR signal-
ing in some cell types, other amino acid sensing mecha-
nisms may also exist. These will be discussed below.
Mechanisms of amino acid signaling
The mechanism by which amino acids stimulate MTOR
activity, and inhibit autophagy, has remained, and still is to
some extent, an enigma for a long time. Amino acids do not
directly stimulate signaling upstream of MTOR, as dis-
cussed above, nor do they stimulate MTOR directly (van
Sluijters et al. 2000; Kim and Guan 2011; Laplante and
Sabatini 2012). However, as discussed in the previous
paragraph, they can do so indirectly by inhibition of
AMPK, depending on the cell type. As also mentioned
earlier, in most cell types, among the various amino acids,
leucine, but not the other branched-chain amino acids
valine and isoleucine, is most potent in inhibiting autoph-
agy and stimulating MTOR, and non-metabolizable ana-
logs of leucine could mimic its effect. Catabolism of
leucine does not seem to be required (Lynch et al. 2003).
Indeed, fibroblasts from patients with defects in leucine
catabolism displayed enhanced MTOR activity (Schriever
et al. 2013). However, a role for leucine catabolites in
MTOR signaling cannot entirely be ruled out. Thus, in
experiments in man, administration of the leucine metab-
olite b-hydroxy-b-methylbutyrate, a compound that in
clinical settings is used to treat disease-related muscle
wasting, has been shown to stimulate skeletal muscle
growth through the MTOR pathway (Wilkinson et al.
2013). It cannot be excluded that this compound, by
serving as an oxidizable substrate, decreases AMPK
activity and in this way stimulates MTOR signaling. A link
between b-hydroxy-b-methylbutyrate-stimulated MTOR
activity and the control of autophagy was not established.
It is concluded that any mechanism of amino acid
sensing must account for the high leucine specificity.
Several factors involved in amino acid-MTOR sig-
naling have been described in the past and have been
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reviewed in detail elsewhere (Dann and Thomas 2006;
Avruch et al. 2009; Meijer and Codogno 2009; Kim and
Guan 2011; Laplante and Sabatini 2012) (Fig. 2). These
include, a.o., MAP4K3, PIK3C3, the G-protein Rheb,
proton-assisted amino acid transporters in the lysosomal
membrane, the Rag GTPases, leucyl-tRNA synthetase,
the adapter protein p62, phospholipase D and inositol
polyphosphate multikinase. The evidence in support of
these various factors relied on the observation that
elimination of any one of them strongly interfered with
the ability of amino acids to stimulate MTOR signaling.
In none of these studies, however, the nature of the
primary amino acid sensor was identified. As will
become clear, some of these factors are part of one
mechanism responsible for the activation of MTOR
activity by amino acids, whereas others participate in
mechanisms that are independent of, but act in parallel
to, each other.
Rheb
A potential mechanism of amino acid sensing was sug-
gested by the observation that amino acids, leucine in
particular, promote the association of Rheb with MTOR
(Long et al. 2005). Although the effect was said not to be
due to increased loading of Rheb with GTP (Long et al.
2005), other data indicate that amino acids did in fact
promote the loading of Rheb with GTP (Smith et al. 2005;
Roccio et al. 2006; Tzatsos and Kandror 2006; Sun and
Chen 2008), but the reason for this increase in GTP loading
was not explained. It is important to stress, however, that in
TSC knockdown cells in which Rheb was fully charged
with GTP, irrespective of the presence of amino acids,
activation of MTOR remained amino acid dependent
(Smith et al. 2005; Roccio et al. 2006). This indicated at
least one other mechanism for amino acid activation of
MTOR activity.
Rag
A big step forward in the search for a mechanism of amino
acid sensing was the demonstration that the Rag GTPases
are essential for the activation of MTOR by amino acids
(Kim et al. 2008; Sancak et al. 2008) and that active
MTORC1 appeared to be localized at the lysosomal
membrane (Sancak et al. 2010). The Rag proteins form
heterodimers between RagA/B and RagC/D, and in its most
active form, RagA/B is in the GTP form and RagC/D in the
GDP form (Tsun et al. 2013). Interestingly, amino acids
increased the charging of RagA/B with GTP (Sancak et al.
2008). It was proposed that the v-ATPase in the lysosomal
membrane, in addition to its role in proton pumping, acts as
the amino acid sensor in MTOR signaling (Zoncu et al.
2011). The v-ATPase responds to an increase in the in-
tralysosomal, rather than the cytosolic, amino acid con-
centration with a conformational change. This causes
increased binding of Ragulator, a scaffolding protein
complex consisting of 5 different proteins with guanine
nucleotide exchange activity toward RagA and RagB,
which anchors the Rag proteins to the lysosomal surface
(Bar-Peled et al. 2012). At the extralysosomal surface
MTORC1 interacts with Rheb and becomes activated.
Recruitment of the MTOR–Rag protein complex to the
lysosome requires binding to the tumor suppressor protein
folliculin. Folliculin is a GTPase-activating protein that
specifically regulates the nucleotide status of RagC/D, not
of RagA/B. Folliculin binding to the lysosome further
requires association with the folliculin interacting proteins-
1 and 2 (Petit et al. 2013; Tsun et al. 2013). A protein
complex, called GATOR, composed of two subcomplexes,
GATOR-1 and -2, also interacts with the Rags. As follic-
ulin, GATOR-1 acts as a GTPase-activating protein but in
this case toward RagA and RagB, not RagC and D, and
thereby suppresses MTORC1 activity (Bar-Peled et al.
2013). Inactivating mutations of its components, which
may occur in cancer, makes MTORC1 signaling resistant
to amino acid deprivation. GATOR-2, in turn, negatively
regulates GATOR-1 so that inhibition of GATOR-2 sup-
presses MTORC1 signaling.
The v-ATPase-mediated mechanism of amino acid
sensing by MTORC1 at the lysosomal surface requires the
proton gradient across the lysosomal membrane (Settembre
et al. 2012). The activity of the lysosomal proton-assisted
amino acid transporter PAT1, responsible for the efflux of
amino acids from the lysosomes, may control the concen-
tration of amino acids within the lysosomal lumen and thus
the extent of MTORC1 activation (Zoncu et al. 2011), but
the participation of other amino acid transporters in the
lysosomal membrane cannot be ruled out (Efeyan et al.
2012). If the mechanism is correct, it must be speculated
that among the various amino acids leucine is specially
active in inducing the conformation change of the v-ATP-
ase. In vitro experiments with isolated lysosomes in which
the conditions for binding to the lysosomal membrane, and
activation, of MTORC1 were analyzed have suggested that
this may, indeed, be the case (Zoncu et al. 2011).
The fact that MTOR activity in MTORC1 is determined
by the size of the intralysosomal pool of amino acids
implies that the use of compounds such as the v-ATPase
inhibitor bafilomycin or the acidotropic agent chloroquine
cannot be recommended to estimate autophagic flux by
monitoring the accumulation of the autophagosomal mar-
ker LC3-II. This is because inhibition of proteolysis within
the lysosomes will directly affect the intralysosomal pool
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of amino acids, and thus leads to underestimation of
MTOR activity and overestimation of autophagic flux
(Juhasz 2012; Klionsky et al. 2012).
Puzzling is a recent report showing that\10 % of total
intracellular Rag colocalized with the lysosomes, although
loss of Rag from the lysosomal fraction to the cytosol
during cell disruption and fractionation by differential
centrifugation on sucrose density gradients could not be
excluded (Oshiro et al. 2013).
In addition to the localization of active MTOR, as part
of MTORC1, at the lysosomal membrane, MTOR present
in MTORC2 is localized at the mitochondria (Schieke et al.
2006; Ramanathan and Schreiber 2009; Betz et al. 2013),
presumably at the mitochondrial-endoplasmic reticulum
contact site where it controls mitochondrial function (Betz
et al. 2013).
Leucyl-tRNA synthetase
An early hypothesis proposed that free, uncharged, tRNA
participates in amino acid sensing (Hara et al. 1998; Iiboshi
et al. 1999). This hypothesis was based on observations
with yeast in which, on amino acid starvation, free tRNA
binds with high affinity to the protein kinase GCN2 (the
equivalent of eIF2a-kinase) because the active center of
GCN2 strongly resembles that of aminoacyl-tRNA syn-
thetases (Hinnebusch 1997; Dong et al. 2000). GCN2
activation results in phosphorylation of eIF2a which then
results in the derepression of GCN4 mRNA translation.
GCN4 (equivalent to mammalian ATF4) is a transcrip-
tional activator that promotes the transcription of many
genes involved in nitrogen metabolism, not only genes
involved in amino acid biosynthesis but also in autophagy
(Natarajan et al. 2001; Tallo´czy et al. 2002; B’chir et al.
2013). The particular potency of leucine in activating
MTOR was proposed to be related to the frequency of
utilization of this amino acid in protein synthesis and by the
existence of multiple leucyl-tRNA synthetases arising from
the sixfold codon degeneracy (Hara et al. 1998). Because
uncharged tRNA did not affect the in vitro activity of
immunoprecipitated MTOR, it was postulated that free
tRNA interacted with an as yet unknown, signal-trans-
duction component regulating MTOR (Iiboshi et al. 1999).
Incompatible with the tRNA hypothesis, however, were
kinetic considerations (the Km of leucine for leu-tRNA
synthetase being orders of magnitude lower than prevailing
intracellular leucine concentrations) and because specific
aminoalcohols, inhibiting leu-tRNA synthetase, did not
affect MTOR signaling (Lynch et al. 2000) (contrast (Ii-
boshi et al. 1999)). Finally, at least in HEK-293 cells, free
tRNA levels did appear to change by amino acid starvation
(Dennis et al. 2001).
Interest in the tRNA mechanism revived with the finding
that leucyl-tRNA synthetase directly binds to Rag GTPase
in a leucine-dependent manner and functions as a GTPase-
activating protein (GAP) for Rag GTPase to activate
MTORC1 (Han et al. 2012). In this mechanism, leucylation
of the tRNA is not required. It is sufficient that leucine
binds to the leucine-binding domain of the leucyl-tRNA
synthetase and activates the enzyme, as measured by ATP-
[32P]PPi exchange activity (Han et al. 2012). In this con-
text, it is noteworthy that diadenosine tetraphosphate
(Ap4A), a byproduct of the aminoacyl-tRNA synthetase
reaction, was previously proposed by us as a factor
involved in MTOR stimulation by amino acids because
Ap4A is a strong inhibitor of AMPK (Meijer 2008).
It is important to stress that the two mechanisms of
amino acid sensing, discussed in the previous paragraphs,
detect different pools of amino acids: The v-ATPase senses
the intralysosomal pool of amino acids, while the leucyl-
tRNA synthetase senses cytosolic leucine. It is perfectly
possible that these two mechanisms coexist in amino acid
sensing (Yoon et al. 2011; Duran and Hall 2012a).
Glutamate dehydrogenase
Some years ago, on the basis of existing literature, we
hypothesized that glutamate dehydrogenase (GDH), in
addition to its role in amino acid catabolism, is involved in
amino acid sensing and in controlling autophagy (Meijer
2008; Meijer and Codogno 2008, 2009). The arguments
were as follows. As discussed earlier, this mitochondrial
enzyme is specifically activated by leucine. In pancreatic
b-cells, the ability of leucine (but not of valine or isoleu-
cine) to stimulate production of insulin and to stimulate
rapamycin-sensitive S6K phosphorylation was ascribed to
stimulation of GDH (Xu et al. 2001). Moreover, a mutation
in GDH, which results in overactivation of the enzyme,
underlies the hyperinsulinism/hyperammonia (HHS) syn-
drome (Li et al. 2012b). A combination of glutamine (a
glutamate donor) and leucine, which maximizes the flux
through GDH, is most effective in stimulating MTOR and
in inhibiting autophagic flux in several cell types, including
a.o., b-cells and hepatocytes ((Meijer and Codogno 2009),
for literature), as discussed earlier (cf. section ‘‘Discovery
of amino acid signaling and its relationship with autoph-
agy’’). Recent studies by Duran et al. (2012) using both
genetic and pharmacological methods have now provided
strong experimental evidence that in the course of gluta-
mine metabolism, GDH does, indeed, play a crucial role in
the activation of MTOR. It was also demonstrated that it is
the production of 2-oxoglutarate by GDH which stimulates
loading of RagB with GTP. The link between 2-oxoglu-
tarate and MTORC1 was proposed to be prolylhydroxylase
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which, in a HIF-1a-independent manner, somehow results
in increased RagBGTP (Duran et al. 2013). In these studies,
the possibility of increased production of GTP by succinyl
CoA synthetase in the course of 2-oxoglutarate oxidation in
the mitochondria, suggested by us in the past (Meijer and
Codogno 2009), was not explored.
By contrast, other data have indicated that the charging
of RagA/B with GTP does not play a role in the mechanism
of amino acid sensing. Thus, Rag heterodimers extracted
from [32P]Pi-labeled whole cells or from the pool associ-
ated with the lysosomal membrane exhibited constitutive
[32P]GTP charging that was unaltered by amino acid
withdrawal. In addition, in cells with mutant Rag which
was unable to bind GTP, activation of MTOR by amino
acids still occurred (Oshiro et al. 2013). Another concern is
that dimethyl-2-oxoglutarate, a cell-permeable analog of
2-oxoglutarate, has been shown to inhibit, rather than
stimulate, MTORC1 activity (Tan and Hagen 2013). The
reason for these differences in results is not clear.
The importance of GDH in the activation of MTOR was
also indicated, albeit indirectly, by studies of van der Vos
et al. (2012) showing that overexpression of glutamine
synthetase inhibited MTOR activity, inhibited the translo-
cation of MTOR to the lysosomes and activated autophagy.
Surprisingly, it was concluded that glutamine itself func-
tions as an inhibitor of MTOR, and thus as an activator of
autophagy, a conclusion which is in contrast to existing
literature (see above). However, the fact that increased flux
through glutamine synthetase results in increased flux
through GDH, in this case in the direction of amination,
i.e., from 2-oxoglutarate to glutamate, because of the use of
glutamate for glutamine synthesis, was overlooked (Duran
and Hall 2012b). In agreement with this interpretation is
the finding that in glutamine-depleted cells pharmacologi-
cal inhibition of glutamine synthetase greatly stimulated
MTOR activity (Tardito et al. 2012).
Apart from a role of GDH in the production of 2-oxo-
glutarate for the activation of MTOR, it is also possible that
NADPH, another product of the deamination reaction,
activates MTOR, and inhibits autophagy, by eliminating
reactive oxygen species (ROS) which are predominantly
produced in the mitochondria (Meijer and Codogno 2009).
This may occur by, e.g., the glutathione–glutathione
reductase system, and/or through direct prevention by
NADPH of ROS production at the FMN-a site of complex I
of the mitochondrial respiratory chain (Albracht et al.
2011). In this context, it is worthwhile to note that gluta-
minase-2 (liver-type), in contrast to glutaminase-1 (kidney-
type), is not sensitive to product inhibition (Kovacevic and
McGivan 1983; Mates et al. 2013). This allows a high flux
through glutaminase and GDH at a relatively high steady-
state intramitochondrial glutamate concentration. This is
not only of importance for production of NADPH via GDH
with its high Km for glutamate but it is also favorable for
the synthesis of glutathione. Interestingly, not only does a
high flux through GDH stimulate MTORC1 but, con-
versely, does MTORC1 activate GDH through transcrip-
tional repression of SIRT4, the mitochondrial localized
sirtuin that inhibits GDH (Csibi et al. 2013). This is very
efficient from the point of view of metabolic regulation.
In addition to NADPH, 2-oxoglutarate, the other product
of the GDH reaction, can also act as a scavenger of ROS,
which oxidizes 2-oxoglutarate to succinate non-enzymi-
cally (Mailloux et al. 2007).
When the production of ROS exceeds its degradation,
excessive ROS levels induce oxidative stress and damage
of cellular components including DNA, proteins and lipids.
A rise in ROS levels (e.g., in starvation) activates
autophagy as a protective mechanism, and this occurs in a
manner that is sensitive to antioxidants (Scherz-Shouval
et al. 2007; Li et al. 2012a; Morales et al. 2014; Rahman
et al. 2014) which, simultaneously, stimulate MTOR
activity (Li et al. 2013). The importance of ROS in the
initiation of autophagy was also indicated by the observa-
tion that knockdown of the antioxidant transcription factor
Nrf2 in breast cancer cells substantially increased autoph-
agy in response to oxidative stress (Rao et al. 2010). Pos-
sible targets of ROS contributing to the stimulation of
autophagy by ROS are ATG4 (Scherz-Shouval and Elazar
2011), PKB (Rahman et al. 2014), Beclin1 (Bolisetty and
Jaimes 2013) and AMPK (Toyoda et al. 2004).
Experiments very recently carried out in our laboratories
(Lorin et al. 2013b) showed that the production of ROS by
starved HeLa cells, a cervix cancer cell line, was sup-
pressed by either a complete mixture of all amino acids or
by a combination of glutamine plus leucine alone.
Knockdown of GDH prevented these effects. At the same
time, knockdown of GDH stimulated autophagy and
inhibited MTOR signaling in the presence of amino acids.
By what mechanism oxidative stress inhibits MTOR is
unknown. Possibilities are increased AMPK and decreased
PKB activities (cf. the previous paragraph). It is also pos-
sible that one, or more, of the components involved in the
amino acid sensing mechanisms discussed above is redox
sensitive. A very recent development is the finding that
TSC1/TSC2 is a target for ROS, in this case of ROS pro-
duced by peroxisomes. Interestingly, both TSC1/TSC2 and
Rheb were found to be bound to peroxisomes and TSC1/
TSC2 became activated by ROS produced by the peroxi-
somes. This resulted in the conversion of peroxisome-
bound RhebGTP to RhebGDP and in inhibition of lysosome-
bound MTORC1 (Zhang et al. 2013). This was accompa-
nied by activation of autophagy. How peroxisomal activa-
tion of TSC1/TSC2 and inhibition of Rheb caused
inactivation of lysosomal MTORC1 was not clear because
MTORC1 did not colocalize with the peroxisomes
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((Benjamin and Hall 2013; Betz and Hall 2013), for dis-
cussion). An attractive mechanism would be that MTORC1,
TSC1/TSC2 and/or Rheb shuttle between various sites in
the cell where ROS is produced locally to bring the signal to
the lysosomes which is considered to be the site responsible
for amino acid activation of MTORC1. In line with this is,
the very recent finding that deprivation of insulin and of
amino acids recruits the TSC complex to the lysosomes
where it acts to inactivate Rheb (Menon et al. 2014; De-
metriades et al. 2014). It will be of interest to see whether a
system similar to that found for peroxisomal ROS is also
present for ROS produced by the mitochondria. Indeed,
association of Rheb and MTORC1 with mitochondria
cannot be excluded (Schieke et al. 2006; Groenewoud and
Zwartkruis 2013).
In this context, it is important to note that glutamine
deprivation in pancreatic cancer cells also resulted in
increased ROS production (Son et al. 2013). Suppression of
ROS by glutamine was ascribed to production of oxalo-
acetate from glutamine-derived aspartate, followed by its
reduction to malate and subsequent production of NADPH
(and pyruvate) by malic enzyme in the cytosol. Elimination
of cytosolic aspartate aminotransferase, indeed, greatly
increased production of ROS, which could be counteracted,
at least in part, by addition of oxaloacetate (Son et al.
2013). However, net production of oxaloacetate from glu-
tamine requires net production 2-oxoglutarate, and this
cannot proceed without the participation of GDH or of
glutamate pyruvate transaminase (Yang et al. 2009). The
finding that addition of oxaloacetate in the absence of
aspartate aminotransferase could suppress ROS accumu-
lation is not surprising because a-oxoacids react non-
enzymically with ROS (Holleman 1904; Andrae et al.
1985; Mailloux et al. 2007).
In retrospect, the participation of glutamate dehydrogenase
in the control of autophagy is in agreement with the obser-
vation that autophagy was stimulated pharmacologically by
the green tea component epigallocatechin gallate (Li et al.
2011; Zhou et al. 2014). This compound is a powerful inhib-
itor of glutamate dehydrogenase (Li et al. 2006), but the link
between these phenomena was not made.
Involvement of GDH in amino acid sensing has serious
consequences for the use of chloroquine in the measure-
ment of autophagic flux. This compound not only
increases the intralysosomal pH and in this way affects
the intralysosomal amino acid pool, as discussed above
(cf. section ‘‘Rag’’) but, in addition, is also a potent
inhibitor of GDH (Jarzyna et al. 1997). This, too, leads to
overestimation of autophagic flux. Along the same line,
stimulation of autophagy by ammonia (Eng et al. 2010;
Harder et al. 2014) may be ascribed to the fact that this
metabolite drives the GDH reaction in the direction of
glutamate synthesis. An alternative, or perhaps additional,
mechanism is activation of AMPK by ammonia (Harder
et al. 2014). It must be pointed out that in the latter
experiments, ammonia was used at mM concentrations.
Although the data indicated that ammonia increased the
rate of autophagosome formation, it is highly likely that
under these conditions the intralysosomal pH was also
affected. Autophagic flux under turnover conditions, as
measured by 3-methyladenine-sensitive proteolysis, was
not analyzed, however.
PIK3C3 and p62/SQSTM1
Some years ago it was proposed that PIK3C3 is required
for amino acid signaling, an effect that is mediated by an
amino acid-induced rise in cytosolic Ca??, which results in
increased binding of Ca??/calmodulin to, and activation
of, PIK3C3 (Nobukuni et al. 2005; Gulati et al. 2008).
Apart from the fact that a rise in Ca??/calmodulin stimu-
lates autophagy through activation of AMPK by calmod-
ulin-dependent kinase–kinase-b (Hoyer-Hansen et al. 2007;
Meijer and Codogno 2009; Pfisterer et al. 2011; Ghislat
et al. 2012) and that it is more likely that cytosolic Ca??
decreases rather than increases in the presence of amino
acids (Meijer and Codogno 2009; Ghislat et al. 2012),
although this issue has been controversial (Wauson et al.
2012), these observations were puzzling because PIK3C3
also participates in the formation of autophagosomes.
A similar problem relates to the proposal that p62/
SQSTM1 participates in amino acid signaling (Duran et al.
2011), because this protein does not inhibit autophagy but
rather is required for this process.
In order to solve the problem with PIK3C3, it was
proposed that the enzyme is part of different protein
complexes with different functions (Kim and Guan 2011;
Ktistakis et al. 2012). Recent experiments indicate that this
is, indeed, the case and that different PIK3C3 complexes
exist which are differentially regulated by amino acids
(Yuan et al. 2013; Kim et al. 2013a).
It has been proposed that amino acids, by locally acti-
vating the formation of PI(3)P, actually stimulate the pro-
duction of PI(3,5)P2 by phosphatidylinositol-3-phosphate-
5-kinase. PI(3,5)P2 is able to bind to RAPTOR where it
serves to recruit MTOR downstream targets and/or to bring
MTORC1 to the proper location in the cell (Bridges et al.
2012; Jin et al. 2014).
p62/SQSTM1 may also be compartmented because
only a small part of the total cellular p62 is bound to
the MTORC1 complex through its association with the
Rag GTPases (Duran et al. 2011). As an alternative
explanation, however, we propose that autophagy itself
produces amino acids which then stimulate MTOR
activity (Shigemitsu et al. 1999a; Beugnet et al. 2003;
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Yu et al. 2010; Inoki et al. 2012). Thus, overexpression
of PIK3C3 or p62 initially activates autophagy, resulting
in increased production of amino acids from proteins
within the lysosomes. This increases the size of the
intralysosomal pool of amino acids which is sensed by
the v-ATPase in the lysosomal membrane and activates
MTOR according to the mechanism discussed above.
Conversely, if PIK3C3 or p62 becomes inhibited, auto-
phagic flux declines, the intralysosomal amino acid pool
decreases and MTOR becomes inhibited. The observa-
tion that in skeletal muscle of mice deficient of myo-
tubularin, the lipid phosphatase responsible for the
degradation of PI(3)P, autophagy is defective and
MTOR overactivated (Fetalvero et al. 2013) may be
explained similarly. Perhaps initially, autophagy is
overactivated because of the rise in PI(3)P. This results
in increased autophagic proteolysis, a rise in the con-
centration of lysosomal amino acids, upon which MTOR
becomes activated and autophagy inhibited again.
Phospholipase D
The phosphatidic acid-producing enzyme phospholipase D
(PLD) (Fang et al. 2001) has also been implicated as one of
the components taking part in the mechanism by which
amino acids activate MTORC1.
It has been reported that amino acids activate PLD1 in a
PIK3C3-dependent manner and that PLD1 is indispensable
for translocation of MTORC1 to the lysosomes and its
activation by amino acids (Yoon et al. 2011; Xu et al.
2011). In the absence of PIK3C3, addition of phosphatidic
acid only activated MTORC1 when amino acids were also
present. Addition of exogenous PI(3)P stimulated PLD1
activity in the absence of amino acids but did not activate
MTORC1 (Yoon et al. 2011). These and other observa-
tions led to the suggestion that PLD1 may be part of the
protein complex anchoring MTORC1 to the lysosomal
membrane and that the PIK3C3-PLD1 pathway acts in
parallel to the Rag pathway in regulating amino acid
activation of MTORC1 (Yoon et al. 2011; Wiczer and
Thomas 2012). Unexpectedly, the effect of PLD1 on
autophagy has been controversial: both stimulation (Dal-
l’Armi et al. 2010) and inhibition (Jang et al. 2014) of
autophagy have been reported. It was suggested that this
dual effect of PLD on autophagy, as with PIK3C3, is
dependent on the subcellular localization of PLD (Jang
et al. 2014). However, as discussed in the previous section,
it cannot be excluded that the PIK3C3-phosphatidic acid
pathway is actually required for autophagy but that
MTORC1 becomes activated after the intralysosomal pool
of amino acids has sufficiently expanded by autophagic
proteolysis.
Inositol polyphosphate multikinase
Inositol polyphosphate multikinase is another component
implicated in the mechanism responsible for stimulation of
MTOR activity by amino acids (Kim et al. 2011b). Inde-
pendent of its catalytic activity the enzyme appeared to
stabilize the binding between MTOR and RAPTOR in the
MTORC1 complex through its aminoterminal amino acid
sequence which forms a unique mammalian MTOR bind-
ing site (Kim et al. 2011b).
MAP4K3
MAP4K3 is another protein that acts upstream (Findlay
et al. 2007; Yan et al. 2010) of MTOR which becomes
activated by amino acids. Its role in amino acid sensing is
not entirely clear. It is unlikely that this kinase participates
in either the v-ATPase or the leucyl-tRNA synthetase
mechanism of amino acid sensing. Presumably, MAP4K3
is part of another pathway leading to amino acid-induced
MTOR activation (Kim and Guan 2011).
Plasma membrane amino acid receptor
Early evidence indicated that the amino acid receptor was
intracellular rather than extracellular (Martin and Suther-
land 2001; Christie et al. 2002; Beugnet et al. 2003).
However, this may not entirely be true. There are indica-
tions that the plasma membrane can also contribute to
amino acid sensing. Thus, it has been suggested that the
plasma membrane of hepatocytes contains a leucine-spe-
cific receptor protein (which does not transport leucine)
which controls autophagy independently of MTOR
(Kanazawa et al. 2004).
In analogy with yeast, plasma membrane amino acid
transporters have also been implicated in the sensing of
(extracellular) amino acid availability by mammalian cells
(Hundal and Taylor 2009; Kim and Guan 2011). Such a
role was attributed to a transport protein that mediates the
exchange between extracellular leucine and intracellular
glutamine, which allows leucine to be transported against a
concentration gradient (Nicklin et al. 2009). It must be
pointed out, however, that an intracellular localization of
the amino acid sensor implies that any process affecting the
intracellular concentration of leucine, whether it is its
transport across the plasma membrane or the rate of the
intracellular metabolism of leucine, will affect the ability
of leucine to stimulate MTOR activity.
Very recently, it was reported that the G-protein-cou-
pled taste receptor complex T1R1/T1R3, an amino acid
receptor in the plasma membrane, originally discovered in
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gustatory neurons as a detector of the umami flavor and
present in many tissues, is an early sensor of extracellular
amino acid availability (Wauson et al. 2012). Reduced
expression of T1R1/T1R3 impaired the activation of
MTOR by amino acids, caused mislocalization of
MTORC1, and accelerated autophagy under nutrient-rich
conditions. Interestingly, the intracellular concentration of
amino acids, leucine included, was not affected by
knockdown of the taste receptor even though the expres-
sion of several plasma membrane amino acid transporters
greatly increased under these conditions (Wauson et al.
2012). The question of how inactivation of MTOR and
activation of autophagy in T1R1/T1R3 receptor knock-
down cells could occur in the absence of changes in
intracellular amino acid concentrations remained unan-
swered. An obvious explanation could be that GDH was
downregulated after knockdown of the taste receptor. But
this is unlikely because this enzyme plays a central role in
amino acid catabolism and its downregulation would have
resulted in increased intracellular amino acid concentra-
tions under these conditions, which was not observed.
Another, plausible, possibility is that AMPK was activated.
However, AMPK was inhibited, instead (Wauson et al.
2012). A third possibility, i.e., that leucyl-tRNA synthetase
was affected by T1R1/T1R3 receptor knockdown, was not
explored.
Amino acid sensing and the concentration of cytosolic
acetyl CoA
A very recent development has been the finding that the
acetyltransferase EP300, responsible for the inhibitory
acetylation of several ATG proteins, because of its low
affinity (high Km) for acetyl CoA, acts as a sensor of
cytosolic acetyl CoA which translates increases in cyto-
solic acetyl CoA into inhibition of autophagy (Marin˜o et al.
2014b). Thus, several experimental manipulations designed
to alter cytosolic acetyl CoA, both in cultured cells and
in vivo in mice, resulted in predicted changes in autophagic
flux. Because the level of cytosolic acetyl CoA also
strongly correlated with the activity of MTORC1 the pos-
sibility that the acetylation-dependent control of autophagy
was indirect and mediated by MTORC1 could not be
excluded (Marin˜o et al. 2014b).
In view of these fascinating observations, it is possible
that amino acid catabolism may actually result in increased
cytosolic acetyl CoA and in this way inhibits autophagy
and stimulates MTORC1 signaling. This, then, would yet
be another mechanism by which amino acids affect these
pathways. Although this remains to be demonstrated, glu-
tamate dehydrogenase, by stimulating synthesis of citrate
followed by exit of citrate from the mitochondria and its
cleavage by ATP-citrate lyase in the cytosol, can be
expected to play an important role here, too.
Amino acid signaling and autophagy: summary
In summary, on the basis of current literature, it is clear
that there is not one unique mechanism of amino acid
sensing. Rather, several mechanisms of amino acid sens-
ing, leading to activation of MTOR, can operate. Whether
these mechanisms are context- and/or cell type-dependent,
or act in parallel, is currently not known.
Although amino acids can inhibit autophagy by activa-
tion of MTOR, they can also do so in an MTOR-inde-
pendent manner. Thus, as we have seen, amino acids can
decrease Beclin1-associated PIK3C3 activity because they
promote the association between Beclin 1 and Bcl-2
through inhibition of JNK1-mediated phosphorylation of
Bcl-2. In addition, amino acids may decrease AMPK
activity which results in dephosphorylation, and inhibition,
of Beclin1 and ULK1. This may explain why the inhibition
of autophagy by amino acids is not always fully reversed
by rapamycin. The inhibition of autophagy by insulin
through protein kinase B-induced phosphorylation of Be-
clin1 and the transcription factor FoxO3 and through the
direct inhibitory effects of PI(3,4)P2 and PI(3,4,5)P3 is also
MTORC1 independent, and thus rapamycin insensitive.
Conclusions
Our original discoveries of amino acid-stimulated, MTOR-
mediated, signaling and its role in the control of autophagy,
the regulation of these two pathways by the energy sensor
AMPK and the role of phosphatidylinositol 3-phosphate in
autophagy have opened new perspectives in the under-
standing of the regulation of cell metabolism. Given the
enormous impact of autophagy on cell function, and its
regulation by amino acid signaling, it is not surprising that
research in these fields has expanded exponentially over
the last two decades (Klionsky 2007; Ohsumi 2014).
Proper in vivo manipulation of autophagy, either pharma-
cologically or by dietary restriction, under many patho-
logical conditions may be used to the benefit of patients
(Hermans et al. 2013). The safest way is dietary restriction.
Although it is known for a very long time to be beneficial
for health, e.g., in obesity, type 2 diabetes and aging, the
underlying mechanisms are still not clear. A simple
explanation is that dietary restriction acts as a two-sided
sword. On the one hand, it reduces the redox pressure on
the mitochondrial respiratory chain, and thus diminishes
overproduction of potentially harmful ROS. On the other
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hand, dietary restriction also stimulates autophagy and
thereby contributes to the improvement of cell function
(Cavallini et al. 2008; Blagosklonny 2010; Gelino and
Hansen 2012; Eisenberg et al. 2014).
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